Clinical Trial Update: LUTEIN BY SCLERAL IONTOPHORESIS IN PATIENTS WITH STAGE 3 AGE-RELATED MACULAR DEGENERATION (AMD)

View source ↗

Summary

This clinical trial update describes a study evaluating lutein delivered via scleral iontophoresis for stage 3 age-related macular degeneration, with recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lutein (lutein)

Snippet

Sponsor: OFFHEALTH S.p.A. | Conditions: DML Stage 3 | Status: NOT_YET_RECRUITING